Blood Disorders Among Women. Implications for Preconception Care

American Journal of Preventive Medicine

Volumn 38, Issue 4 SUPPL., 2010, Pages

  Ebrahim, Shahul H ^a   Kulkarni, Roshni ^a   Parker, Christopher ^a   Atrash, Hani K ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD DISEASE; DIET SUPPLEMENTATION; FEMALE; HEALTH HAZARD; HUMAN; MACROCYTIC ANEMIA; MATERNAL CARE; MATERNAL NUTRITION; PREGNANCY; PREGNANCY OUTCOME; PRENATAL SCREENING; PREVALENCE; QUALITY OF LIFE; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA; THROMBOCYTOPENIA; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; VON WILLEBRAND DISEASE; WOMEN'S HEALTH;

FEMALE; HEMATOLOGIC DISEASES; HUMANS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; RISK;

EID: 77949476007     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2009.12.018     Document Type: Review

References (57)

1. U.S. Public Health Service Expert Panel on the Content of Prenatal Care. Caring for our future: the content of prenatal care (1989), USDHHS, Washington DC
2. CDC. Recommendations to improve preconception health and health care-U.S. MMWR Morb Mortal Wkly Rep 55 No. RR-6 (2006)
3. Weatherall D., Hofman K., Rodgers G., et al. A case for developing North-South partnerships for research in sickle cell disease. Blood 105 (2005) 921-923
4. Makani J., Williams T.N., and Marsh K. Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol 101 (2007) 3-14
5. Modell B., and Darlison M. Global epidemiology of hemoglobin disorders and derived service indicators. Bull World Health Organ 86 (2008) 480-487
6. Soucie J.M., Evatt B., and Jackson D. Occurrence of hemophilia in the U.S. Am J Hematol 59 (1998) 288-294
7. In: Bick R., Frenkel E., Baker W., and Sarode R. (Eds). Hematological complications in obstetrics, pregnancy, and gynecology (2006), Cambridge University Press, New York
8. Philipp C., Faiz A., Dowling N., et al. Age and the prevalence of bleeding disorders in women with menorrhagia. J Obstet Gynecol 105 (2005) 61-66
9. James A.H., Kouides P.A., Abdul-Kadir R., et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 201 (2009) 12.e1-12.e8
10. Kadir R., Chi C., and Bolton-Maggs P. Pregnancy and rare bleeding disorders. Haemophilia 15 (2009) 990-1005
11. Allen L.H. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 71 Suppl 5 (2000 May) 1280S-4S
12. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: Anemia in pregnancy. Obstet Gynecol 112 (2008) 201-207
13. CDC. Iron deficiency-U.S., 1999-2000. MMWR Morb Mortal Wkly Rep 51 (2002) 897-899
14. Anderson Jr. F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151 5 (1991) 933-938
15. Cusick S.E., Mei Z., Freedman D.S., et al. Unexplained decline in the prevalence of anemia among U.S. children and women between 1988-1994 and 1999-2002. Am J Clin Nutr 88 6 (2008) 1611-1617
16. Cogswell M.E., Kettel-Khan L., and Ramakrishnan U. Iron supplement use among women in the U.S.: science, policy and practice. J Nutr 133 6 (2003) S1974-S1977
17. Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion 46 (2006) 1667-1681
18. Wheeler S. Assessment and interpretation of micronutrient status during pregnancy. Proc Nutr Soc 67 (2008) 437-450
19. Vlachos A., Ball S., Dahl N., et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 142 (2008) 859-876
20. Faivre L., Meerpohl J., Da Costa L., et al. High-risk pregnancies in Diamond Blackfan anemia: a survey of 64 pregnancies from the French and German registries. Haematologica 91 (2006) 530-533
21. Alter B.P., Frissora C.L., Halpérin D.S., et al. Fanconi's anaemia and pregnancy. Br J Haematol 77 3 (1991) 410-418
22. Skordis N., Petrikkos L., Toumba M., et al. Update on fertility in thalassemia major. Pediatr Endocrinol Rev 2 2S (2004) S296-S302
23. Nassar A.H., Naja M., Cesaretti C., Eprassi B., Cappellini M.D., and Taher A. Pregnancy outcome in patients with beta-thalassemia intermedia at two tertiary care centers, in Beirut and Milan. Haematologica 93 10 (2008) 1586-1587
24. Origa R., Piga A., Quarta G., et al. Pregnancy and {beta}-thalassemia: an Italian multicenter experience. Haematologica (2009 Nov 10) [Epub ahead of print].
25. Hoppe C. Newborn screening for non-sickling hemoglobinopathies. Hematology 2009. American Society of Hematology Education Program Book (2009) 19-25
26. Oliver S., Dezateux C., Kavanagh J., Lempert T., and Stewart R. Disclosing to parents newborn carrier status identified by routine blood spot screening. Cochrane Database Syst Rev 4 (2004) CD003859
27. Korenbrot C., Steinberg A., Bender C., and Newberry S. Preconception care: a systematic review. Matern Child Health J 6 2 (2002) 75-88
28. Letsky E.A. Blood disorders in pregnancy. Chapter 13.16. In: Warrell D.A., Cox T.M., and Firth J.D. (Eds). Oxford textbook of medicine. 4th ed. Vol 2 (2003), Oxford University Press, New York
29. Levitt C. Preconception health promotion. Primary care. Clinics in Office Practice 20 (1993) 537-549
30. Health Canada. Family-centered maternity and newborn care: national guidelines (2000), Minister of Public Works and Government Services, Ottawa. www.hc-sc.gc.ca
31. U.S. Census Bureau News. Nation's population to reach 300 million on Oct. 17 (October 12, 2006), U.S. Department of Commerce Public Information Office. www.census.gov/Press-Release/www/releases/archives/population/007616.html
32. Anderson Jr. F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151 5 (1991) 933-938
33. Seligsohn U., and Griffin J.H. Hereditary thrombophilia. In: Lichtman M., Beutler E., Kipps T., Seligsohn U., Kaushansky K., and Prchal J. (Eds). Williams hematology (2006), McGraw-Hill Publishers, Columbus OH
34. Rosendaal F.R. Venous thrombosis: the role of genes, environment, and behavior. Hematology/Am Soc Hematol Educ Program (2005) 1-12
35. Cushman M. Inherited risk factors for venous thrombosis. Hematology/Am Soc Hematol Educ Program (2005) 452-457
36. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., and Melton III L.J. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160 6 (2000) 809-815
37. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3S (2004) S338-S400
38. Baglin T.P., White K., and Charles A. Fatal pulmonary embolism in hospitalized medical patients. J Clin Pathol 50 7 (1997) 609-610
39. Vossen C.Y., Conard J., Fontcuberta J., et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 3 3 (2005) 459-464
40. Di Minno G., Mannucci P., Tufano A., et al. The first ambulatory screening on thromboembolism: a multicenter, cross-sectional, observational study on risk factors for venous thromboembolism. J Thromb Haemost 3 (2005) 1459-1466
41. Rathburn S. Venous thromboembolism in women. Vasc Med 13 (2008) 255-266
42. James A., Brancazio L.R., and Ortel T.L. Prevention of venous thromboembolism. NIH Consensus Development. JAMA 256 6 (1986) 744-749
43. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. Clin Adv Hematol Oncol 3 (2005) 187-197
44. Lockwood C.J. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 99 (2002) 333-341
45. Silver R.M., and Warren J.E. Preconception counseling for women with thrombophilia. Clin Obstet Gynecol 49 (2006) 906-919
46. Wu O., Robertson L., Twaddle S., et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 10 (2006) 1-110
47. Lin L., and August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105 (2005) 182-192
48. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
49. American College of Obstetrics and Gynecology. Thromboembolism in pregnancy. Practice Bulletin No.19 (2000), American College of Obstetricians and Gynecologists, Washington
50. Prins M.H., Raskob G.E., Büller H.R., Agnelli G.., Hull R.D., and Hyers T.M. Thromboembolic disease antithrombotic therapy for venous. Chest 126 3 Suppl 6B (2004) 401S-428S. http://chestjournal.chestpubs.org/content/126/3_suppl/401S.full.html http://chestjournal.chestpubs.org/content/126/3_suppl/401S.full.html
51. Dunlop A.L., Jack B.W., Bottalico J.N., et al. The clinical content of preconception care: women with chronic medical conditions. Am J Obstet Gynecol 199 (2008) S310-S327
52. Chi C., and Kadir R.A. Management of women with inherited bleeding disorders in pregnancy. Obstetrician Gynecologist 9 1 (2007) 27-33
53. Lethagen S., Harris A.S., Sjorin E., and Nilsson I.M. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 58 (1987) 1033-1036
54. Verdy E., Bessous V., Dreyfus M., Kaplan C., Tchernia G., and Uzan S. Longitudinal analysis of platelet count and volume in normal pregnancy. Thromb Haemost 77 (1997) 806-807
55. Sukenik-Halevy R., Ellis M.H., and Fejgin M.D. Management of immune thrombocytopenic purpura in pregnancy. Obstet Gynecol Surv 63 3 (2008) 182-188
56. Serjeant G.R. Geographic heterogeneity of sickle cell disease. In: Steinberg M.H., Forget B.G., Higgs D.R., and Nagel R.L. (Eds). Disorders of hemoglobin (2001), Cambridge University Press, Cambridge, UK
57. Gelpi A.P. Benign sickle cell disease in Saudi Arabia: survival estimates and population dynamics. Clin Genet 15 (1979) 307-310